Vol. 14 No. 4 (2008)

Published: 2008-10-01

Editorial

Continuing education in biotechnology

Yali Friedman
- PDF

Article

Can compliance help marketing and business development?

John Avellanet
- PDF
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers

Laura Heinonen, Birgitta Sandberg
- PDF
Got value? Determine it. Demonstrate it. Communicate it. Realise it

Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg, Shibani Pokras
- PDF
Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development â€“ Commonalities and differences in portfolio management practice

Kerstin M Bode-Greuel, Klaus J Nickisch
- PDF

From the Classroom

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies

Arlen D Meyers, Donald J McCubbrey, Richard T Watson
- PDF

Legal and Regulatory Updates

Legal and regulatory update

Gerry Kamstra, John Wilkinson
- PDF

Book Review

Book Review: The Regulatory Challenge of Biotechnology

John Avellanet
- PDF
Book Review: Intellectual Property and Biotechnology: Biological Inventions

Stefan M Miller
- PDF
Book Review: Commercializing Successful Biomedical Technologies

Arlen D Meyers
- PDF
Book Review: Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences

Arlen D Meyers
- PDF
Best Practices in Biotechnology Business Development

Hans-Erik Hamid Lydecker
- PDF
Genetic Glass Ceilings: Transgenics for Crop Biodiversity

Drew L Kershen
- PDF
Biotechnology and the Law

Edward L Korwek
- PDF
Welcome to Biotech Nation

James Rogers
- PDF